ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.254,27
1,01%
S&P 500
6.086,37
0,61%
Dow Jones
44.156,73
0,30%
Euro vs US Dollar
1,04093
0,01%
Bitcoin
102.057,95
-1,52%
Pepperstone
Advertisement
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Acurx Pharmaceuticals Inc (ACXP) Börsenkurse

Acurx Pharmaceuticals Inc

Acurx Pharmaceuticals Inc (ACXP)

NASDAQ
0,8481
-0,0419
(-4,71%)
Geschlossen 23 Januar 10:00PM
Verzögert um 15 Minuten
0,8599
0,0118
(1,39%)
Nach Börsenschluss: 1:50AM
Verzögert um 15 Minuten

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Wichtige Statistiken und Details

Current Price
0,8599
Gebot
0,8391
Fragen
0,85
Volumen
191.674
0,82 Tagesbereich 0,899
0,68 52-Wochen-Bereich 4,15
Marktkapitalisierung
14,526M
Handelsende
0,89
Handelsbeginn
0,899
Letzte Trade
122
@
0.8599
(formt)
Letzter Handelszeitpunkt
Finanzvolumen
US$ 164.309
VWAP
0,857232
Durchschnittliches Volumen (3 Mio.)
283.135
Ausgegebene Aktien
16.892.548
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-1,00
Gewinn pro Aktie (EPS)
-0,86
Erlöse
-
Nettogewinn
-14,58M

Über Acurx Pharmaceuticals Inc

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.acurxpharma.com
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Acurx Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ACXP. The last closing price for Acurx Pharmaceuticals was US$0,89. Over the last year, Acurx Pharmaceuticals shares have traded in a share price range of US$ 0,68 to US$ 4,15.

Acurx Pharmaceuticals currently has 16.892.548 shares in issue. The market capitalisation of Acurx Pharmaceuticals is US$15,03 million. Acurx Pharmaceuticals has a price to earnings ratio (PE ratio) of -1.00.

ACXP Neueste Nachrichten

Weitere Nachrichten

Form 4 - Statement of changes in beneficial ownership of securities

08 Januar 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

08 Januar 2025
Edgar (US Regulatory)

Acurx Pharmaceuticals, Inc. Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Acurx Pharmaceuticals, Inc. Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules PR Newswire STATEN ISLAND, N.Y., Jan. 7, 2025 STATEN ISLAND, N.Y...

07 Januar 2025
PR Newswire (US)

Form 424B5 - Prospectus [Rule 424(b)(5)]

07 Januar 2025
Edgar (US Regulatory)

Form 8-K - Current report

07 Januar 2025
Edgar (US Regulatory)

Acurx Pharmaceuticals, Inc. Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Acurx Pharmaceuticals, Inc. Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules PR Newswire STATEN ISLAND, N.Y., Jan. 6, 2025 STATEN ISLAND, N.Y., Jan. 6...

06 Januar 2025
PR Newswire (US)

Form 424B3 - Prospectus [Rule 424(b)(3)]

06 Januar 2025
Edgar (US Regulatory)

Acurx Receives Positive Regulatory Guidance from EMA for Ibezapolstat Phase 3 Program for C. Difficile Infection (CDI)

Acurx Receives Positive Regulatory Guidance from EMA for Ibezapolstat Phase 3 Program for C. Difficile Infection (CDI) PR Newswire STATEN ISLAND, N.Y., Jan. 6, 2025 Acurx has now received...

06 Januar 2025
PR Newswire (US)

Acurx Updates Phase 3 Readiness for Ibezapolstat in C. difficile Infection Based on Recent FDA and EMA Communications

Acurx Updates Phase 3 Readiness for Ibezapolstat in C. difficile Infection Based on Recent FDA and EMA Communications PR Newswire STATEN ISLAND, N.Y., Dec. 9, 2024 Following the previously...

09 Dezember 2024
PR Newswire (US)

Acurx Board of Directors Approves Bitcoin as Treasury Reserve Asset

Acurx Board of Directors Approves Bitcoin as Treasury Reserve Asset PR Newswire STATEN ISLAND, N.Y., Nov. 20, 2024 STATEN ISLAND, N.Y., Nov. 20, 2024 /PRNewswire/ -- Acurx Pharmaceuticals, Inc...

20 November 2024
PR Newswire (US)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.159922.84285714290.70.9050.693891420.84807056CS
4-0.0201-2.284090909090.881.250.685460140.83137229CS
12-1.0862-55.81419248751.94611.950.682831350.94168369CS
26-1.6201-65.32661290322.482.56960.681502051.13971438CS
52-2.6801-75.7090395483.544.150.681170001.6797021CS
156-2.8501-76.82210242593.718.820.681322902.95405551CS
260-5.0901-85.54789915975.958.820.681510103.86120819CS

ACXP - Frequently Asked Questions (FAQ)

What is the current Acurx Pharmaceuticals share price?
The current share price of Acurx Pharmaceuticals is US$ 0,8599
How many Acurx Pharmaceuticals shares are in issue?
Acurx Pharmaceuticals has 16.892.548 shares in issue
What is the market cap of Acurx Pharmaceuticals?
The market capitalisation of Acurx Pharmaceuticals is USD 15,03M
What is the 1 year trading range for Acurx Pharmaceuticals share price?
Acurx Pharmaceuticals has traded in the range of US$ 0,68 to US$ 4,15 during the past year
What is the PE ratio of Acurx Pharmaceuticals?
The price to earnings ratio of Acurx Pharmaceuticals is -1
What is the reporting currency for Acurx Pharmaceuticals?
Acurx Pharmaceuticals reports financial results in USD
What is the latest annual profit for Acurx Pharmaceuticals?
The latest annual profit of Acurx Pharmaceuticals is USD -14,58M
What is the registered address of Acurx Pharmaceuticals?
The registered address for Acurx Pharmaceuticals is 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808
What is the Acurx Pharmaceuticals website address?
The website address for Acurx Pharmaceuticals is www.acurxpharma.com
Which industry sector does Acurx Pharmaceuticals operate in?
Acurx Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
BLBXBlackBoxStocks Inc
US$ 5,53
(227,22%)
229,08M
ASSTAsset Entities Inc
US$ 1,36
(51,11%)
121,68M
STAIScanTech AI Systems Inc
US$ 2,12
(44,22%)
51,68M
JYDJayud Global Logistics Ltd
US$ 3,53
(42,91%)
1,27M
NTRBNutriband Inc
US$ 7,39
(41,84%)
3,88M
STFSStar Fashion Culture Holdings Ltd
US$ 2,62
(-80,61%)
30,25M
HEPAHepion Pharmaceuticals Inc
US$ 0,135
(-58,05%)
39,89M
STBXStarBox Group Holdings Ltd
US$ 0,6201
(-36,50%)
1,63M
WHLRLWheeler Real Estate Investment Trust Inc
US$ 93,51
(-35,73%)
1
JUNSJupiter Neurosciences Inc
US$ 3,61
(-33,39%)
6,87M
IPAImmunoPrecise Antibodies Ltd
US$ 0,6446
(30,75%)
296,43M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,3191
(33,57%)
229,11M
BLBXBlackBoxStocks Inc
US$ 5,53
(227,22%)
229,08M
NVDANVIDIA Corporation
US$ 147,07
(4,43%)
216,62M
RGTIRigetti Computing Inc
US$ 13,89
(-0,64%)
154,54M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
ACXP
Acurx Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten